結膜炎薬の世界市場動向・分析2018-2025

【英語タイトル】Global Conjunctivitis Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D02324)・商品コード:QYR8D02324
・発行会社(調査会社):QYResearch
・発行日:2018年11月20日
・ページ数:119
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥539,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,078,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、結膜炎薬の世界市場について調査・分析し、種類別には、抗生物質、肥満細胞安定剤、ステロイド、その他に、用途別には、病院、セルフ投与に区分してまとめました。調査対象企業は、Akorn Pharmaceuticals、Alcon/ Novartis、Allergan、Bausch & Lomb、Valeant Pharmaceuticals、Merck、Actavis、Pfizer等です。

・レポートの概要
・グローバル成長トレンド
・結膜炎薬の世界市場規模
・結膜炎薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別結膜炎薬の価格動向
・結膜炎薬の種類別市場規模(抗生物質、肥満細胞安定剤、ステロイド、その他)
・結膜炎薬の用途別市場規模(病院、セルフ投与)
・結膜炎薬の北米市場(アメリカ、カナダ、メキシコ)
・結膜炎薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・結膜炎薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・結膜炎薬の中南米市場(ブラジル等)
・結膜炎薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Akorn Pharmaceuticals、Alcon/ Novartis、Allergan、Bausch & Lomb、Valeant Pharmaceuticals、Merck、Actavis、Pfizer)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・結膜炎薬の市場規模予測
・結膜炎薬の種類別市場予測2018-2025(抗生物質、肥満細胞安定剤、ステロイド、その他)
・結膜炎薬の用途別市場予測2018-2025(病院、セルフ投与)
・結膜炎薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・結膜炎薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・結膜炎薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・結膜炎薬の中南米市場予測2018-2025(ブラジル等)
・結膜炎薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Conjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in kerato-conjunctivitis, which results in blurred vision. The viral and bacterial conjunctivitis results in highly infectious watery discharge which is extremely contagious.The market for conjunctivitis is growing at a moderate rate. The growth factors for the growth of global conjunctivitis drugs market are rise in hygiene and awareness, growing expenditure on health, greater exposure to allergens and infective agents, the contagious nature of the disease etc. However the market is restrained by many factors such as the self-limiting nature of the disease, off label drug use,
In 2018, the global Conjunctivitis Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Conjunctivitis Drugs.

This study researches the market size of Conjunctivitis Drugs, presents the global Conjunctivitis Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Conjunctivitis Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Conjunctivitis Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Akorn Pharmaceuticals
Alcon/ Novartis
Allergan
Bausch & Lomb
Valeant Pharmaceuticals
Merck
Actavis
Pfizer

Market Segment by Product Type
Antibiotics
Mast Cell Stabilizers
Steroids
Others

Market Segment by Application
Hospitals
Self-Administered

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Conjunctivitis Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Conjunctivitis Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Conjunctivitis Drugs are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Conjunctivitis Drugs Market Size Growth Rate by Type
1.3.2 Antibiotics
1.3.3 Mast Cell Stabilizers
1.3.4 Steroids
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Conjunctivitis Drugs Market Share by Application (2018-2025)
1.4.2 Hospitals
1.4.3 Self-Administered
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Conjunctivitis Drugs Market Size
2.1.1 Global Conjunctivitis Drugs Revenue 2013-2025
2.1.2 Global Conjunctivitis Drugs Sales 2013-2025
2.2 Conjunctivitis Drugs Growth Rate by Regions
2.2.1 Global Conjunctivitis Drugs Sales by Regions 2013-2018
2.2.2 Global Conjunctivitis Drugs Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Conjunctivitis Drugs Sales by Manufacturers
3.1.1 Conjunctivitis Drugs Sales by Manufacturers 2013-2018
3.1.2 Conjunctivitis Drugs Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Conjunctivitis Drugs Revenue by Manufacturers (2013-2018)
3.2.2 Conjunctivitis Drugs Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Conjunctivitis Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Conjunctivitis Drugs Price by Manufacturers
3.4 Key Manufacturers Conjunctivitis Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Conjunctivitis Drugs Market
3.6 Key Manufacturers Conjunctivitis Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Antibiotics Sales and Revenue (2013-2018)
4.1.2 Mast Cell Stabilizers Sales and Revenue (2013-2018)
4.1.3 Steroids Sales and Revenue (2013-2018)
4.1.4 Others Sales and Revenue (2013-2018)
4.2 Global Conjunctivitis Drugs Sales Market Share by Type
4.3 Global Conjunctivitis Drugs Revenue Market Share by Type
4.4 Conjunctivitis Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Conjunctivitis Drugs Sales by Application

6 North America
6.1 North America Conjunctivitis Drugs Breakdown Data by Company
6.2 North America Conjunctivitis Drugs Breakdown Data by Type
6.3 North America Conjunctivitis Drugs Breakdown Data by Application
6.4 North America Conjunctivitis Drugs Breakdown Data by Countries
6.4.1 North America Conjunctivitis Drugs Sales by Countries
6.4.2 North America Conjunctivitis Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Conjunctivitis Drugs Breakdown Data by Company
7.2 Europe Conjunctivitis Drugs Breakdown Data by Type
7.3 Europe Conjunctivitis Drugs Breakdown Data by Application
7.4 Europe Conjunctivitis Drugs Breakdown Data by Countries
7.4.1 Europe Conjunctivitis Drugs Sales by Countries
7.4.2 Europe Conjunctivitis Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Conjunctivitis Drugs Breakdown Data by Company
8.2 Asia Pacific Conjunctivitis Drugs Breakdown Data by Type
8.3 Asia Pacific Conjunctivitis Drugs Breakdown Data by Application
8.4 Asia Pacific Conjunctivitis Drugs Breakdown Data by Countries
8.4.1 Asia Pacific Conjunctivitis Drugs Sales by Countries
8.4.2 Asia Pacific Conjunctivitis Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Conjunctivitis Drugs Breakdown Data by Company
9.2 Central & South America Conjunctivitis Drugs Breakdown Data by Type
9.3 Central & South America Conjunctivitis Drugs Breakdown Data by Application
9.4 Central & South America Conjunctivitis Drugs Breakdown Data by Countries
9.4.1 Central & South America Conjunctivitis Drugs Sales by Countries
9.4.2 Central & South America Conjunctivitis Drugs Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Conjunctivitis Drugs Breakdown Data by Type
10.2 Middle East and Africa Conjunctivitis Drugs Breakdown Data by Application
10.3 Middle East and Africa Conjunctivitis Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Conjunctivitis Drugs Sales by Countries
10.3.2 Middle East and Africa Conjunctivitis Drugs Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Akorn Pharmaceuticals
11.1.1 Akorn Pharmaceuticals Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Conjunctivitis Drugs
11.1.4 Conjunctivitis Drugs Product Introduction
11.1.5 Akorn Pharmaceuticals Recent Development
11.2 Alcon/ Novartis
11.2.1 Alcon/ Novartis Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Conjunctivitis Drugs
11.2.4 Conjunctivitis Drugs Product Introduction
11.2.5 Alcon/ Novartis Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Conjunctivitis Drugs
11.3.4 Conjunctivitis Drugs Product Introduction
11.3.5 Allergan Recent Development
11.4 Bausch & Lomb
11.4.1 Bausch & Lomb Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Conjunctivitis Drugs
11.4.4 Conjunctivitis Drugs Product Introduction
11.4.5 Bausch & Lomb Recent Development
11.5 Valeant Pharmaceuticals
11.5.1 Valeant Pharmaceuticals Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Conjunctivitis Drugs
11.5.4 Conjunctivitis Drugs Product Introduction
11.5.5 Valeant Pharmaceuticals Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Conjunctivitis Drugs
11.6.4 Conjunctivitis Drugs Product Introduction
11.6.5 Merck Recent Development
11.7 Actavis
11.7.1 Actavis Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Conjunctivitis Drugs
11.7.4 Conjunctivitis Drugs Product Introduction
11.7.5 Actavis Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Conjunctivitis Drugs
11.8.4 Conjunctivitis Drugs Product Introduction
11.8.5 Pfizer Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Conjunctivitis Drugs Sales Channels
12.2.2 Conjunctivitis Drugs Distributors
12.3 Conjunctivitis Drugs Customers

13 Market Forecast
13.1 Global Conjunctivitis Drugs Sales and Revenue Forecast 2018-2025
13.2 Global Conjunctivitis Drugs Sales Forecast by Type
13.3 Global Conjunctivitis Drugs Sales Forecast by Application
13.4 Conjunctivitis Drugs Forecast by Regions
13.4.1 Global Conjunctivitis Drugs Sales Forecast by Regions 2018-2025
13.4.2 Global Conjunctivitis Drugs Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Conjunctivitis Drugs Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Conjunctivitis Drugs Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Conjunctivitis Drugs Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Conjunctivitis Drugs Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Conjunctivitis Drugs Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Conjunctivitis Drugs Product Picture
Table Conjunctivitis Drugs Key Market Segments
Table Major Manufacturers Conjunctivitis Drugs Covered in This Report
Table Global Conjunctivitis Drugs Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Conjunctivitis Drugs Sales Market Shar by Type 2013-2025
Figure Antibiotics Figures
Table Major Manufacturers of Antibiotics
Figure Mast Cell Stabilizers Figures
Table Major Manufacturers of Mast Cell Stabilizers
Figure Steroids Figures
Table Major Manufacturers of Steroids
Figure Others Figures
Table Major Manufacturers of Others
Table Global Conjunctivitis Drugs Market Share by Application 2018-2025 (K Units)
Figure Hospitals Use Case
Figure Self-Administered Use Case
Figure Conjunctivitis Drugs Report Years Considered
Figure Global Conjunctivitis Drugs Market Size 2013-2025 (Million US$)
Figure Global Conjunctivitis Drugs Sales 2013-2018 (K Units)
Table Global Conjunctivitis Drugs Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Conjunctivitis Drugs Sales by Regions 2013-2018 (K Units)
Table Global Conjunctivitis Drugs Sales Market Share by Regions 2013-2018
Figure Global Conjunctivitis Drugs Sales Market Share by Regions 2013-2018
Figure Global Conjunctivitis Drugs Sales Market Share by Regions in 2018
Table Global Conjunctivitis Drugs Revenue by Regions 2013-2018 (Million US$)
Table Global Conjunctivitis Drugs Revenue Market Share by Regions 2013-2018
Figure Global Conjunctivitis Drugs Revenue Market Share by Regions 2013-2018
Figure Global Conjunctivitis Drugs Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Conjunctivitis Drugs Sales by Manufacturers (2013-2018) (K Units)
Table Global Conjunctivitis Drugs Sales Share by Manufacturers (2013-2018)
Figure Global Conjunctivitis Drugs Sales Share by Manufacturers in 2018
Table Conjunctivitis Drugs Revenue by Manufacturers (2013-2018) (Million USD)
Table Conjunctivitis Drugs Revenue Share by Manufacturers (2013-2018)
Figure Conjunctivitis Drugs Value Share by Manufacturers in 2018
Table Global Conjunctivitis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Conjunctivitis Drugs Price (2013-2018) (USD/Unit)
Table Key Manufacturers Conjunctivitis Drugs Plants/Factories Distribution
Table Key Manufacturers Conjunctivitis Drugs Area Served
Table Date of Key Manufacturers Enter into Conjunctivitis Drugs Market
Table Key Manufacturers Conjunctivitis Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Antibiotics Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Mast Cell Stabilizers Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Steroids Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Others Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Conjunctivitis Drugs Sales by Type (2013-2018) (K Units)
Table Global Conjunctivitis Drugs Sales Share by Type (2013-2018)
Figure Global Conjunctivitis Drugs Sales Market Share by Type (2013-2018)
Figure Global Conjunctivitis Drugs Sales Market Share by Type in 2017
Table Global Conjunctivitis Drugs Revenue by Type (2013-2018) (Million US$)
Table Global Conjunctivitis Drugs Revenue Share by Type (2013-2018)
Figure Global Conjunctivitis Drugs Revenue Market Share by Type (2013-2018)
Figure Global Conjunctivitis Drugs Revenue Market Share by Type in 2017
Table Conjunctivitis Drugs Price by Type 2013-2018 (USD/Unit)
Table Global Conjunctivitis Drugs Sales by Application (2013-2018) (K Units)
Table Global Conjunctivitis Drugs Sales Share by Application (2013-2018)
Figure Global Sales Conjunctivitis Drugs Market Share by Application (2013-2018)
Figure Global Sales Conjunctivitis Drugs Market Share by Application in 2017
Figure North America Conjunctivitis Drugs Sales Growth Rate 2013-2018 (K Units)
Figure North America Conjunctivitis Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table North America Conjunctivitis Drugs Sales by Company (2013-2018) (K Units)
Table North America Conjunctivitis Drugs Sales Market Share by Company (2013-2018)
Figure North America Conjunctivitis Drugs Sales Market Share by Company in 2018
Table North America Conjunctivitis Drugs Sales by Type (2013-2018) (K Units)
Table North America Conjunctivitis Drugs Sales Market Share by Type (2013-2018)
Figure North America Conjunctivitis Drugs Market Share by Type in 2018
Table North America Conjunctivitis Drugs Sales by Application (2013-2018) (K Units)
Table North America Conjunctivitis Drugs Sales Market Share by Application (2013-2018)
Figure North America Conjunctivitis Drugs Market Share by Application in 2018
Table North America Conjunctivitis Drugs Sales by Countries (2013-2018) (K Units)
Table North America Conjunctivitis Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 North America Conjunctivitis Drugs Sales Market Share by Countries
Table North America Conjunctivitis Drugs Revenue by Countries (2013-2018) (Million US$)
Table North America Conjunctivitis Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Conjunctivitis Drugs Revenue Market Share by Countries
Figure United States Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Canada Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Europe Conjunctivitis Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Europe Conjunctivitis Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Conjunctivitis Drugs Sales by Company (2013-2018) (K Units)
Table Europe Conjunctivitis Drugs Sales Market Share by Company (2013-2018)
Figure Europe Conjunctivitis Drugs Sales Market Share by Company in 2018
Table Europe Conjunctivitis Drugs Sales by Type (2013-2018) (K Units)
Table Europe Conjunctivitis Drugs Sales Market Share by Type (2013-2018)
Figure 2017 Europe Conjunctivitis Drugs Market Share by Type
Table Europe Conjunctivitis Drugs Sales by Application (2013-2018) (K Units)
Table Europe Conjunctivitis Drugs Sales Market Share by Application (2013-2018)
Figure 2017 Europe Conjunctivitis Drugs Market Share by Application
Table Europe Conjunctivitis Drugs Sales by Countries (2013-2018) (K Units)
Table Europe Conjunctivitis Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Conjunctivitis Drugs Sales Market Share by Countries
Table Europe Conjunctivitis Drugs Revenue by Countries (2013-2018) (Million US$)
Table Europe Conjunctivitis Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Conjunctivitis Drugs Revenue Market Share by Countries in 2018
Figure Germany Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure France Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure UK Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Italy Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Russia Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Conjunctivitis Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Conjunctivitis Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Conjunctivitis Drugs Sales by Company (2013-2018) (K Units)
Table Asia Pacific Conjunctivitis Drugs Sales Market Share by Company (2013-2018)
Figure Asia Pacific Conjunctivitis Drugs Sales Market Share by Company in 2018
Table Asia Pacific Conjunctivitis Drugs Sales by Type (2013-2018) (K Units)
Table Asia Pacific Conjunctivitis Drugs Sales Market Share by Type (2013-2018)
Figure Asia Pacific Conjunctivitis Drugs Market Share by Type in 2018
Table Asia Pacific Conjunctivitis Drugs Sales by Application (2013-2018) (K Units)
Table Asia Pacific Conjunctivitis Drugs Sales Market Share by Application (2013-2018)
Figure Asia Pacific Conjunctivitis Drugs Market Share by Application in 2018
Table Asia Pacific Conjunctivitis Drugs Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Conjunctivitis Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Conjunctivitis Drugs Sales Market Share by Countries
Table Asia Pacific Conjunctivitis Drugs Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Conjunctivitis Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Conjunctivitis Drugs Revenue Market Share by Countries
Figure China Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure China Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Japan Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Korea Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure India Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure India Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Australia Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Conjunctivitis Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Conjunctivitis Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Conjunctivitis Drugs Sales by Company (2013-2018) (K Units)
Table Central & South America Conjunctivitis Drugs Sales Market Share by Company (2013-2018)
Figure Central & South America Conjunctivitis Drugs Sales Market Share by Company in 2018
Table Central & South America Conjunctivitis Drugs Sales by Type (2013-2018) (K Units)
Table Central & South America Conjunctivitis Drugs Sales Market Share by Type (2013-2018)
Figure Central & South America Conjunctivitis Drugs Market Share by Type in 2018
Table Central & South America Conjunctivitis Drugs Sales by Application (2013-2018) (K Units)
Table Central & South America Conjunctivitis Drugs Sales Market Share by Application (2013-2018)
Figure Central & South America Conjunctivitis Drugs Market Share by Application in 2018
Table Central & South America Conjunctivitis Drugs Sales by Countries (2013-2018) (K Units)
Table Central & South America Conjunctivitis Drugs Sales Market Share by Countries (2013-2018)
Figure Central & South America Conjunctivitis Drugs Sales Market Share by Countries in 2018
Table Central & South America Conjunctivitis Drugs Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Conjunctivitis Drugs Revenue Market Share by Countries (2013-2018)
Figure Central & South America Conjunctivitis Drugs Revenue Market Share by Countries in 2018
Figure Brazil Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Conjunctivitis Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Conjunctivitis Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Conjunctivitis Drugs Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Conjunctivitis Drugs Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Conjunctivitis Drugs Market Share by Type
Table Middle East and Africa Conjunctivitis Drugs Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Conjunctivitis Drugs Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Conjunctivitis Drugs Market Share by Application
Table Middle East and Africa Conjunctivitis Drugs Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Conjunctivitis Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Conjunctivitis Drugs Sales Market Share by Countries
Table Middle East and Africa Conjunctivitis Drugs Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Conjunctivitis Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Conjunctivitis Drugs Revenue Market Share by Countries
Figure GCC Countries Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Conjunctivitis Drugs Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Conjunctivitis Drugs Revenue Growth Rate (2013-2018) (K Units)
Table Akorn Pharmaceuticals Company Details
Table Akorn Pharmaceuticals Description and Business Overview
Table Akorn Pharmaceuticals Conjunctivitis Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Akorn Pharmaceuticals Conjunctivitis Drugs Sales Growth Rate (2013-2018)
Table Akorn Pharmaceuticals Conjunctivitis Drugs Sales Market Share in Global Market
Table Akorn Pharmaceuticals Recent Development
Table Alcon/ Novartis Company Details
Table Alcon/ Novartis Description and Business Overview
Table Alcon/ Novartis Conjunctivitis Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Alcon/ Novartis Conjunctivitis Drugs Sales Growth Rate (2013-2018)
Table Alcon/ Novartis Conjunctivitis Drugs Sales Market Share in Global Market
Table Alcon/ Novartis Recent Development
Table Allergan Company Details
Table Allergan Description and Business Overview
Table Allergan Conjunctivitis Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Allergan Conjunctivitis Drugs Sales Growth Rate (2013-2018)
Table Allergan Conjunctivitis Drugs Sales Market Share in Global Market
Table Allergan Recent Development
Table Bausch & Lomb Company Details
Table Bausch & Lomb Description and Business Overview
Table Bausch & Lomb Conjunctivitis Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bausch & Lomb Conjunctivitis Drugs Sales Growth Rate (2013-2018)
Table Bausch & Lomb Conjunctivitis Drugs Sales Market Share in Global Market
Table Bausch & Lomb Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Description and Business Overview
Table Valeant Pharmaceuticals Conjunctivitis Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Valeant Pharmaceuticals Conjunctivitis Drugs Sales Growth Rate (2013-2018)
Table Valeant Pharmaceuticals Conjunctivitis Drugs Sales Market Share in Global Market
Table Valeant Pharmaceuticals Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Conjunctivitis Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck Conjunctivitis Drugs Sales Growth Rate (2013-2018)
Table Merck Conjunctivitis Drugs Sales Market Share in Global Market
Table Merck Recent Development
Table Actavis Company Details
Table Actavis Description and Business Overview
Table Actavis Conjunctivitis Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Actavis Conjunctivitis Drugs Sales Growth Rate (2013-2018)
Table Actavis Conjunctivitis Drugs Sales Market Share in Global Market
Table Actavis Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Conjunctivitis Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer Conjunctivitis Drugs Sales Growth Rate (2013-2018)
Table Pfizer Conjunctivitis Drugs Sales Market Share in Global Market
Table Pfizer Recent Development
Figure Conjunctivitis Drugs Value Chain
Table Conjunctivitis Drugs Distributors List
Table Conjunctivitis Drugs Customers List
Table Global Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Global Conjunctivitis Drugs Revenue Forecast 2018-2025 (Million US$)
Table Global Conjunctivitis Drugs Sales Forecast by Type 2018-2025 (K Units)
Figure Global Conjunctivitis Drugs Sales Forecast by Type 2018-2025 (K Units)
Figure Global Conjunctivitis Drugs Sales Market Share Forecast by Type 2018-2025
Table Global Conjunctivitis Drugs Sales Forecast by Application 2018-2025 (K Units)
Figure Global Conjunctivitis Drugs Sales Forecast by Application 2018-2025 (K Units)
Figure Global Conjunctivitis Drugs Sales Market Share Forecast by Application 2018-2025
Table Global Conjunctivitis Drugs Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Conjunctivitis Drugs Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Conjunctivitis Drugs Sales Market Share Forecast by Regions 2018-2025
Table Global Conjunctivitis Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Conjunctivitis Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Conjunctivitis Drugs Revenue Market Share Forecast by Regions 2018-2025
Table North America Conjunctivitis Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table North America Conjunctivitis Drugs Sales Market Share Forecast by Countries 2018-2025
Table North America Conjunctivitis Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Conjunctivitis Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure United States Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Canada Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure MexicoConjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Table Europe Conjunctivitis Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Conjunctivitis Drugs Sales Market Share Forecast by Countries 2018-2025
Table Europe Conjunctivitis Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Conjunctivitis Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure France Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure UK Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Italy Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Russia Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Conjunctivitis Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Conjunctivitis Drugs Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Conjunctivitis Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Conjunctivitis Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure China Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Japan Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Korea Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure India Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Australia Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Indonesia Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Thailand Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Malaysia Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Philippines Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Figure Vietnam Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Table Central & South America Conjunctivitis Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Conjunctivitis Drugs Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Conjunctivitis Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Conjunctivitis Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Conjunctivitis Drugs Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Conjunctivitis Drugs Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Conjunctivitis Drugs Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Conjunctivitis Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Conjunctivitis Drugs Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Conjunctivitis Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Conjunctivitis Drugs Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Conjunctivitis Drugs Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Akorn Pharmaceuticals、Alcon/ Novartis、Allergan、Bausch & Lomb、Valeant Pharmaceuticals、Merck、Actavis、Pfizer

★調査レポート[結膜炎薬の世界市場動向・分析2018-2025] (コード:QYR8D02324)販売に関する免責事項を必ずご確認ください。
★調査レポート[結膜炎薬の世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆